Retatrutide is a triple agonist activating GLP-1, GIP, and glucagon receptors, while Ozempic (semaglutide) is a single GLP-1 agonist
Common physical withdrawal symptoms include: Muscle aches, joint pain (particularly in the back and limbs) flu-like symptoms, including a runny nose, excessive tearing, and temperature regulation problems, such as hot flashes and chills Gastrointestinal distress presents as nausea, vomiting, diarrhea, and abdominal cramping Sleep disturbances, difficulty falling asleep, frequent nighttime awakening, and nonrestorative sleep patterns
Final Thoughts: Peptide Therapy as a Hopeful Frontier for Depression Treatment peptide therapy using CJC-1295 and BPC-157 offers a promising new avenue to explore
This will ensure that youre planning the right type of IV therapy
Choose semaglutide if: Semaglutide is likely the better option for several specific profiles